Zydus Lifesciences Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
4,542.90
4,422.80
5,175.60
5,048.40
4,400.80
Other Income Qtr Cr37.7054.0036.0037.8038.50
Operating Revenues Qtr4,505.204,368.805,139.605,010.604,362.30

*All values are in Cr.

Operating Expenses Qtr
3,402.80
3,222.70
3,634.30
3,755.00
3,406.30
Operating Profit Qtr
1,102.40
1,146.10
1,505.30
1,255.60
956.00
EBIDT Qtr Cr
1,161.90
1,199.10
1,526.10
689.90
994.90
Depreciation Qtr
194.80
184.20
179.80
178.60
181.60
Net Profit Qtr
789.60
800.70
1,086.90
296.60
622.90
Basic EPS Qtr
7.80
7.91
10.74
2.93
6.15
Open Demat Account
or Resume your Application
+91 -

personImage